Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BEHRENS M KATHLEEN
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brown Ryan Edward
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodino-Klapac Louise
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murray Dallan
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arif Bilal
Sarepta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Sarepta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Sarepta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Sarepta Therapeutics | 8-K: Current report
Sarepta Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.7%)
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murray Dallan
Sarepta Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Murray Dallan
Sarepta Therapeutics | 10-Q: Quarterly report
Sarepta Therapeutics | DEF 14A: Definitive information statements
Sarepta Therapeutics | ARS: Annual Report to Security Holders
Sarepta Therapeutics | DEFA14A: Others
Sarepta Therapeutics | S-8 POS: S-8 POS
Sarepta Therapeutics | S-8 POS: S-8 POS
Sarepta Therapeutics | S-8 POS: S-8 POS
No Data